SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/274521"
 

Search: id:"swepub:oai:gup.ub.gu.se/274521" > Biomarkers for Anti...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Kranaster, L. (author)

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • 2018-08-17
  • S. Karger AG,2018

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/274521
  • https://gup.ub.gu.se/publication/274521URI
  • https://doi.org/10.1159/000491401DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: No candidate biomarkers based on cerebrospinal fluid (CSF) have been identified as prognostic factors in patients with major depression treated with electroconvulsive therapy (ECT), yet. Method: Following different underlying hypotheses, we analysed baseline CSF levels of markers of neurodegeneration (tau proteins, -amyloids and neurogranin), elements of the innate immune system (interleukin [IL]-6, neopterin, soluble CD14, soluble CD163, migration inhibitory factor and monocyte chemotactic protein 1), endocannabinoids, sphingolipids and Klotho before ECT inpatients with depression (n = 12) to identify possible correlations with the clinical antidepressant response to ECT. Results: Correlation with the reduction of the depressive symptoms could be observed especially for markers of neurodegeneration and elements of the innate immune system. Differences for CSF levels of several markers were found between the groups of responders and non-responders at the trend level. Limitations: The sample size is small and the distribution of responders and non-responders is uneven. Conclusions: It is this first study on CSF biomarkers for antidepressant efficacy of ECT warrants further research regarding the mechanism of ECT and personalized antidepressant therapy.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hoyer, C. (author)
  • Aksay, S. (author)
  • Bumb, J. M. (author)
  • Muller, N. (author)
  • Zill, P. (author)
  • Schwarz, M. J. (author)
  • Moll, N. (author)
  • Lutz, B. (author)
  • Bindila, L. (author)
  • Zerr, I. (author)
  • Schmitz, M. (author)
  • Blennow, Kaj,1958Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xbleka (author)
  • Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xzethe (author)
  • Haffner, D. (author)
  • Leifheit-Nestler, M. (author)
  • Ozbalci, C. (author)
  • Janke, C. (author)
  • Thiel, M. (author)
  • Sartorius, A. (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi (creator_code:org_t)

Related titles

  • In:Neuropsychobiology: S. Karger AG77:1, s. 13-220302-282X1423-0224

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view